Hydrops fetalis – has there been a change in diagnostic spectrum and mortality?

References

• Huang HR, Tsay PK, Chiang MC, Lien R, Chou YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol 2007;24:33–38.
   PubMed Web of Science ®Google Scholar
• Oury JF, Fiblec BL, Nisand I, Muller F. Nonimmune fetal ascites: a series of 79 cases. Am J Obstet Gynecol 2004;190:407–412.
   PubMed Web of Science ®Google Scholar
• Bukowski R, Saade GR. Hydrops fetalis. Clin Perinatol 2000;27:1007–1031.
   PubMed Web of Science ®Google Scholar
• Graves GR, Baskett TF. Nonimmune hydrops fetalis: antenatal diagnosis and management. Am J Obstet Gynecol 1984;148:563–565.
   PubMed Web of Science ®Google Scholar
• Andersen HM, Drew JH, Beischer NA, Hutchison AA, Fortune DW. Non-immune hydrops fetalis: changing contribution to perinatal mortality. Br J Obstet Gynaecol 1983;90:636–639.
   PubMedGoogle Scholar
• Maidman JE, Yeager C, Anderson V, Makabali G, O'Grady JP, Arce J, Tishler DM. Prenatal diagnosis and management of nonimmunologic hydrops fetalis. Obstet Gynecol 1980; 56:571–576.
   PubMed Web of Science ®Google Scholar
• Brown BS. The ultrasonographic features of nonimmune hydrops fetalis: a study of 30 successive patients. Can Assoc Radiol J 1986;37:164–168.
   PubMed Web of Science ®Google Scholar
• Swain S, Cameron AD, McNay MB, Howatson AG. Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust N Z J Obstet Gynaecol 1999;39:285–290.
   PubMed Web of Science ®Google Scholar
• Thompson PJ, Greenough A, Brooker R, Nicolaides KH, Gamsu HR. Antenatal diagnosis and outcome in hydrops fetalis. J Perinat Med 1993;21:63–67.
   PubMed Web of Science ®Google Scholar
• Wafelman LS, Pollock BH, Kreutzer J, Richards DS, Hutchison AA. Nonimmune hydrops fetalis: fetal and neonatal outcome during 1983–1992. Biol Neonate 1999; 75:73–81.
   PubMedGoogle Scholar
• Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 2007;120:84–89.
   PubMed Web of Science ®Google Scholar
• Ratanasiri T, Komwilaisak R, Sittivech A, Kleebkeaw P, Seejorn K. Incidence, causes and pregnancy outcomes of hydrops fetalis at Srinagarind Hospital, 1996–2005: a 10-year review. J Med Assoc Thai 2009;92:594–599.
   PubMedGoogle Scholar
• Ng YP, Joseph R, Biswas A. Homozygous α-thalassemia in a growth retarded, non-hydropic premature newborn. J Perinatol 2008;28:158–159.
   PubMed Web of Science ®Google Scholar
• Wang C, Ryan G. Transfusion medicine illustrated: intrauterine transfusion for homozygous α(0) thalassemia reverses hydrops fetalis. Transfusion 2009;49:1043–1044.
   PubMed Web of Science ®Google Scholar
• Karnpean R, Fucharoen G, Fucharoen S, Sae-ung N, Sanchaisuriya K, Ratanasiri T. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system. Acta Haematol 2009;121:227–233.
   PubMed Web of Science ®Google Scholar
• Liu JZ, Yan M, Wang LR, Wang ZY, Fan YP, Xiao B, Zhou Y. Molecular prenatal diagnosis of α-thalassemia using real-time and multiplex polymerase chain reaction methods. Hemoglobin 2008;32:553–560.
   PubMed Web of Science ®Google Scholar
• Pornprasert S, Phusua A, Suanta S, Saetung R, Sanguansermsri T. Detection of α-thalassemia-1 Southeast Asian type using real-time gap-PCR with SYBR Green1 and high resolution melting analysis. Eur J Haematol 2008;80:510–514.
   PubMed Web of Science ®Google Scholar
• Simpson JH, McDevitt H, Young D, Cameron AD. Severity of non-immune hydrops fetalis at birth continues to predict survival despite advances in perinatal care. Fetal Diagn Ther 2006;21:380–382.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Kukita J, Hikino S, Nakano H, Hara T. Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis. Acta Paediatr 1999;88:24–28.
   PubMed Web of Science ®Google Scholar
• Wy CA, Sajous CH, Loberiza F, Weiss MG. Outcome of infants with a diagnosis of hydrops fetalis in the 1990s. Am J Perinatol 1999;16:561–567.
   PubMed Web of Science ®Google Scholar
• Trainor B, Tubman R. The emerging pattern of hydrops fetalis – incidence, aetiology and management. Ulster Med J 2006;75:185–186.
   PubMedGoogle Scholar
• Hansmann M, Gembruch U, Bald R. New therapeutic aspects in nonimmune hydrops fetalis based on four hundred and two prenatally diagnosed cases. Fetal Ther 1989;4:29–36.
   PubMedGoogle Scholar
• Bellini C, Hennekam RC, Bonioli E. A diagnostic flow chart for non-immune hydrops fetalis. Am J Med Genet A 2009;149A:852–853.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Van Maldergem L, De Munter C, Moscoso G, Gillerot Y. Nonimmune hydrops fetalis associated with genetic abnormalities. Obstet Gynecol 1990;75:568–572.
   PubMed Web of Science ®Google Scholar
• Machin GA. Hydrops revisited: literature review of 1,414 cases published in the 1980s. Am J Med Genet 1989;34:366–390.
   PubMed Web of Science ®Google Scholar
• Turkel SB. Conditions associated with nonimmune hydrops fetalis. Clin Perinatol 1982;9:613–625.
   PubMed Web of Science ®Google Scholar
• Kattner E, Schäfer A, Harzer K. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr 1997;156:292–295.
   PubMed Web of Science ®Google Scholar
• Loren DJ, Campos Y, d'Azzo A, Wyble L, Grange DK, Gilbert-Barness E, White FV, Hamvas A. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal α-neuraminidase. J Perinatol 2005;25:491–494.
   PubMedGoogle Scholar
• Kepron C, Blumenthal A, Chitayat D, Cutz E, Superti-Furga A, Keating S. An autophagic vacuolar myopathy-like disorder presenting as nonimmune hydrops in a female fetus. Pediatr Dev Pathol 2009;12:53–58.
   PubMed Web of Science ®Google Scholar
• Spear GS, Beutler E, Hungs M. Congenital Gaucher disease with nonimmune hydrops/erythroblastosis, infantile arterial calcification, and neonatal hepatitis/fibrosis. Clinicopathologic report with enzymatic and genetic analysis. Fetal Pediatr Pathol 2007;26:153–168.
   PubMed Web of Science ®Google Scholar
• Burin MG, Scholz AP, Gus R, Sanseverino MT, Fritsh A, Magalhaes JA, Timm F, Barrios P, Chesky M, Coelho JC, et al Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn 2004;24:653–657.
   PubMed Web of Science ®Google Scholar
• Ghalamkarpour A, Debauche C, Haan E, Van Regemorter N, Sznajer Y, Thomas D, Revencu N, Gillerot Y, Boon LM, Vikkula M. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. J Pediatr 2009;155:90–93.
   PubMed Web of Science ®Google Scholar
• Piraud M, Froissart R, Mandon G, Bernard A, Maire I. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). Clin Chim Acta 1996;248:143–155.
   PubMed Web of Science ®Google Scholar
• Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat 2000;15:1881–1888.
   Web of Science ®Google Scholar
• Tasso MJ, Martinez-Gutierrez A, Carrascosa C, Vazquez S, Tebar R. GM1-gangliosidosis presenting as nonimmune hydrops fetalis: a case report. J Perinat Med 1996;24:445–449.
   PubMed Web of Science ®Google Scholar
• Sinelli MT, Motta M, Cattarelli D, Cardone ML, Chirico G. Fetal hydrops in GM(1) gangliosidosis: a case report. Acta Paediatr 2005;94:1847–1849.
   PubMed Web of Science ®Google Scholar
• Kooper AJ, Janssens PM, de Groot AN, Liebrand-van Sambeek ML, van den Berg CJ, Tan-Sindhunata GB, an den Berg PP, Bijlsma EK, Smits AP, Wevers RA. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta 2006;371:176–182.
   PubMed Web of Science ®Google Scholar
• Meizner I, Levy A, Carmi R, Robinsin C. Niemann-Pick disease associated with nonimmune hydrops fetalis. Am J Obstet Gynecol 1990;163:128–129.
   PubMed Web of Science ®Google Scholar
• Vidgoff J. Nonimmune hydrops in fetal Niemann-Pick disease. Am J Obstet Gynecol 1991;164:231–232.
   PubMed Web of Science ®Google Scholar
• Colmant C, Picone O, Froissart R, Labrune P, Senat MV. Second-trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis. Prenat Diagn 2006;26:750–752.
   PubMed Web of Science ®Google Scholar
• Geipel A, Berg C, Germer U, Krapp M, Kohl M, Gembruch U. Mucopolysaccharidosis VII (Sly disease) as a cause of increased nuchal translucency and non-immune fetal hydrops: study of a family and technical approach to prenatal diagnosis in early and late pregnancy. Prenat Diagn 2002;22:493–495.
   PubMed Web of Science ®Google Scholar
• Venkat-Raman N, Sebire NJ, Murphy KW. Recurrent fetal hydrops due to mucopolysaccharidoses type VII. Fetal Diagn Ther 2006;21:250–254.
   PubMed Web of Science ®Google Scholar
• Beck M, Bender SW, Reiter HL, Otto W, Bassler R, Dancygier H, Gehler J. Neuraminidase deficiency presenting as non-immune hydrops fetalis. Eur J Pediatr 1984;143:135–139.
   PubMed Web of Science ®Google Scholar
• Godra A, Kim DU, D'Cruz C. Pathologic quiz case: a 5-day-old boy with hydrops fetalis. Mucolipidoses I (Sialidosis III). Arch Pathol Lab Med 2003;127:1051–1052.
   PubMedGoogle Scholar
• Lemyre E, Russo P, Melancon SB, Gagne R, Potier M, Lambert M. Clinical spectrum of infantile free sialic acid storage disease. Am J Med Genet 1999;82:385–391.
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Jacobs D, Cantz M, Hansmann M, Fahnenstich H, Zerres K. Nonimmune hydrops fetalis with galactosialidosis: consequences for family planning. Fetal Diagn Ther 1996;11:114–119.
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Yogev Y, Levit O, Hod M, Kaplan B. Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol 2003;21:297–298.
   PubMed Web of Science ®Google Scholar
• Cox PM, Brueton LA, Murphy KW, Worthington VC, Bjelogrlic P, Lazda EJ, Sabire NJ, Sewry CA. Early-onset fetal hydrops and muscle degeneration in siblings due to a novel variant of type IV glycogenosis. Am J Med Genet 1999;86:187–193.
   PubMed Web of Science ®Google Scholar
• Alegria A, Martins E, Dias M, Cunha A, Cardoso ML, Maire I. Glycogen storage disease type IV presenting as hydrops fetalis. J Inherit Metab Dis 1999;22:330–332.
   PubMed Web of Science ®Google Scholar
• Ferreira P, Morais L, Costa R, Resende C, Dias CP, Araujo F, Costa E, Barbot J, Vilarinho A. Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency. Eur J Pediatr 2000;159:481–482.
   PubMed Web of Science ®Google Scholar
• Gallagher PG, Weed SA, Tse WT, Benoit L, Morrow JS, Marchesi SL, Mohandas N, Forget BG. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte β-spectrin gene. J Clin Invest 1995;95:1174–1182.
   PubMed Web of Science ®Google Scholar
• Yetgin S, Aytac S, Gurakan F, Yurdakok M. Nonimmune hydrops fetalis in two cases of consanguineous parents and associated with hereditary spherocytosis and hemophagocytic hystiocytosis. J Perinatol 2007;27:252–254.
   PubMed Web of Science ®Google Scholar
• Carver C, Brice G, Mansour S, Ostergaard P, Mortimer P, Jeffery S. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet 2007;71:187–189.
   PubMed Web of Science ®Google Scholar
• Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000;67:1382–1388.
   PubMed Web of Science ®Google Scholar
• Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns JP, Van Steensel MA, Vikkula M. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003;72:1470–1478.
   PubMed Web of Science ®Google Scholar
• Hidaka N, Tsukimori K, Hojo S, Nakanami N, Fukushima K, Yamawaki K, Ohno T, Wake N. Transplacental digitalization for nonimmune hydrops fetalis caused by isolated noncompaction of the ventricular myocardium. J Ultrasound Med 2007;26:519–524.
   PubMed Web of Science ®Google Scholar
• Richards A, Mao CY, Dobson NR. Left ventricular noncompaction: a rare cause of hydrops fetalis. Pediatr Cardiol 2009;30:985–988.
   PubMed Web of Science ®Google Scholar
• Phibbs RH, Johnson P, Kitterman JA, Gregory GA, Tooley WH. Cardiorespiratory status of erythroblastotic infants. 1. Relationship of gestational age, severity of hemolytic diseases, and birth asphyxia to idiopathic respiratory distress syndrome and survival. Pediatrics 1972;49:5–14.
   PubMed Web of Science ®Google Scholar
• Carlson DE, Platt LD, Medearis AL, Horenstein J. Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol 1990;163:1785–1787.
   PubMed Web of Science ®Google Scholar
• Castillo RA, Devoe LD, Hadi HA, Martin S, Geist D. Nonimmune hydrops fetalis: clinical experience and factors related to a poor outcome. Am J Obstet Gynecol 1986;155:812–816.
   PubMed Web of Science ®Google Scholar
• Skoll MA, Sharland GK, Allan LD. Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol 1991;1:309–312.
   PubMed Web of Science ®Google Scholar
• Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001;138:92–100.
   PubMed Web of Science ®Google Scholar